Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Recognised for his outstanding contributions to the field of immunology, Michael becomes the fourth Kennedy professor to be elected to the Academy.

Horizontal portrait of Professor Michael Dustin

The National Academy of Sciences (NAS) announced today that Dr Michael L. Dustin is among its 120 newly elected members, recognising distinguished and continuing achievements in original research. Dr Dustin is Professor of Molecular Immunology, and Director of Research at the Kennedy Institute for Rheumatology at NDORMS.  

Professor Fiona Powrie, Director of the Kennedy Institute of Rheumatology, who was also elected to NAS in 2020 said: “Membership of NAS is one of the highest honours a US scientist can receive, and Mike is highly deserving. The award recognises his international leadership in molecular immunology and pioneering work to understand how T lymphocytes recognise and respond to target cells. This has been fundamental for modern day efforts to develop new therapies that target the T cell response, including in immune-oncology. 

“Being elected to NAS is a great honour for me as I was elected by many of my most respected peers from the fields of immunology, cell biology and across the sciences,” said MichaelMy work is highly collaborative, so this is also a recognition of my mentors, including Scott Peterson, Tim Springer, Stuart Kornfeld and Emil Unanue, and all the technicians, students, post-docs, and visiting professors who have spent time in my lab over the past 40 years in science. I'm grateful for all the effort and ingenuity from peers and lab members that my induction into NAS also recognises.” 

On congratulating Michael, Professor Tony Hunter, Molecular and Cell Biology Laboratory, at the Salk Institute, La Jolla, California said: "This is a truly well-deserved recognition of your pioneering work on the reconstitution of the immune synapse on supported lipid bilayers, and what it has taught us."

Michael is the fourth professor from the Kennedy Institute to have been elected to NAS. 

NAS is a private, non-profit institution that was established under a congressional charter signed by President Abraham Lincoln in 1863. It recognises achievement in science by election to membership, and—with the National Academy of Engineering and the National Academy of Medicine—provides science, engineering, and health policy advice to the federal government and other organisations. 

Similar stories

Matthew Costa elected Fellow of Academy of Medical Sciences

Matthew Costa, Professor of Orthopaedic Trauma Surgery at NDORMS, has been elected a Fellow of the Academy of Medical Sciences.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

REF 2021 results for medical research in Oxford

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021.

Nurses' Day 2022

Today marks Nurses' Day 2022. This year's theme is #BestofNursing, so we chatted to some of our amazing Research Nurses about what the Best of Nursing means to them.

Rethinking pain management after injury

NDORMS researchers are to study whether a pain management treatment using cognitive behavioural therapy will improve recovery for people who have had a major leg injury.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.